(3S)-3-(4-HYDROXYPHENYL)-4-HEXYNOIC ACID, 95.0%, 100mg

4-Bromo-5-iodopyridin-2-amine, 95.0%, 1g

3-Bromo-4,5-difluorotoluene, 5g

3-Fluoro-4-trifluoromethoxybenzene boronic acid, 95.0%, 25g

tert-butyl (2S)-2-[4-(4-iodophenyl)-1H-imidazol-2-yl]pyrrolidine-1-carboxylate, 97%, 5g

1-(3-Chloro-5-fluoro-2-hydroxyphenyl)ethan-1-one, 95%, 10g

N,N-dimethylformamide D7, 99.5 at%D, 5 ml, glass packaging

2-Chloro-3-fluoropyridine, 96.0%, 25g

5-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-methylbenzamide, 99.0%, 1g

4-Amino-3-chlorobenzoic acid, 97.0%, 10g

3-Chloro-2,4,6-trifluorobenzaldehyde, 95.0%, 250mg

�-Nicotinamide Adenine Dinucleotide Phosphate Sodium Salt Hydrate, oxidized form [for Biochemical Research], 90.0%, 1g

Ethyl 3-chlorobenzoate, 98.0%, 100g